ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eukaryotic Transcriptome Sequencing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35E13514
Home | Market Reports | Science| Biological Sciences
Global Eukaryotic Transcriptome Sequencing Market Research Report 2023
BUY CHAPTERS

Global Eukaryotic Transcriptome Sequencing Market Research Report 2025

Code: QYRE-Auto-35E13514
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
Bio Rad
Agilent Technologies
Qiagen NV
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang biology
Novogene
Macrogen
Tsingke Biotechnology Co., Ltd.

Eukaryotic Transcriptome Sequencing Market

The global market for Eukaryotic Transcriptome Sequencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Eukaryotic Transcriptome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Eukaryotic Transcriptome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Eukaryotic Transcriptome Sequencing in Biomedical Field is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Eukaryotic Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eukaryotic Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eukaryotic Transcriptome Sequencing.
The Eukaryotic Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eukaryotic Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eukaryotic Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Eukaryotic Transcriptome Sequencing Market Report

Report Metric Details
Report Name Eukaryotic Transcriptome Sequencing Market
Segment by Type
  • Total RNA
  • Noncoding RNA
Segment by Application
  • Biomedical Field
  • Non-medical Field
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, BGI Genomics, Zhijiang Biology, Novogene Co., Ltd, Macrogen, Tsingke Biotechnology Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Eukaryotic Transcriptome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Eukaryotic Transcriptome Sequencing Market report?

Ans: The main players in the Eukaryotic Transcriptome Sequencing Market are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, BGI Genomics, Zhijiang Biology, Novogene Co., Ltd, Macrogen, Tsingke Biotechnology Co., Ltd.

What are the Application segmentation covered in the Eukaryotic Transcriptome Sequencing Market report?

Ans: The Applications covered in the Eukaryotic Transcriptome Sequencing Market report are Biomedical Field, Non-medical Field

What are the Type segmentation covered in the Eukaryotic Transcriptome Sequencing Market report?

Ans: The Types covered in the Eukaryotic Transcriptome Sequencing Market report are Total RNA, Noncoding RNA

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Total RNA
1.2.3 Noncoding RNA
1.3 Market by Application
1.3.1 Global Eukaryotic Transcriptome Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eukaryotic Transcriptome Sequencing Market Perspective (2020-2031)
2.2 Global Eukaryotic Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Eukaryotic Transcriptome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Eukaryotic Transcriptome Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Eukaryotic Transcriptome Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Eukaryotic Transcriptome Sequencing Market Dynamics
2.3.1 Eukaryotic Transcriptome Sequencing Industry Trends
2.3.2 Eukaryotic Transcriptome Sequencing Market Drivers
2.3.3 Eukaryotic Transcriptome Sequencing Market Challenges
2.3.4 Eukaryotic Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eukaryotic Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Eukaryotic Transcriptome Sequencing Players by Revenue (2020-2025)
3.1.2 Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Eukaryotic Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Eukaryotic Transcriptome Sequencing Revenue
3.4 Global Eukaryotic Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Eukaryotic Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eukaryotic Transcriptome Sequencing Revenue in 2024
3.5 Global Key Players of Eukaryotic Transcriptome Sequencing Head office and Area Served
3.6 Global Key Players of Eukaryotic Transcriptome Sequencing, Product and Application
3.7 Global Key Players of Eukaryotic Transcriptome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Eukaryotic Transcriptome Sequencing Breakdown Data by Type
4.1 Global Eukaryotic Transcriptome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Eukaryotic Transcriptome Sequencing Forecasted Market Size by Type (2026-2031)
5 Eukaryotic Transcriptome Sequencing Breakdown Data by Application
5.1 Global Eukaryotic Transcriptome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Eukaryotic Transcriptome Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Eukaryotic Transcriptome Sequencing Market Size (2020-2031)
6.2 North America Eukaryotic Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025)
6.4 North America Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Eukaryotic Transcriptome Sequencing Market Size (2020-2031)
7.2 Europe Eukaryotic Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025)
7.4 Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Eukaryotic Transcriptome Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Eukaryotic Transcriptome Sequencing Market Size (2020-2031)
9.2 Latin America Eukaryotic Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025)
9.4 Latin America Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Eukaryotic Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Eukaryotic Transcriptome Sequencing Introduction
11.3.4 Bio-Rad Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.3.5 Bio-Rad Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Eukaryotic Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Details
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Eukaryotic Transcriptome Sequencing Introduction
11.5.4 QIAGEN Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.5.5 QIAGEN Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Eukaryotic Transcriptome Sequencing Introduction
11.6.4 Roche Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Details
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences Eukaryotic Transcriptome Sequencing Introduction
11.7.4 Pacific Biosciences Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.7.5 Pacific Biosciences Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Eukaryotic Transcriptome Sequencing Introduction
11.8.4 Eurofins Scientific Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.8.5 Eurofins Scientific Recent Development
11.9 Azenta
11.9.1 Azenta Company Details
11.9.2 Azenta Business Overview
11.9.3 Azenta Eukaryotic Transcriptome Sequencing Introduction
11.9.4 Azenta Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.9.5 Azenta Recent Development
11.10 LabCorp
11.10.1 LabCorp Company Details
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Eukaryotic Transcriptome Sequencing Introduction
11.10.4 LabCorp Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.10.5 LabCorp Recent Development
11.11 BGI Genomics
11.11.1 BGI Genomics Company Details
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics Eukaryotic Transcriptome Sequencing Introduction
11.11.4 BGI Genomics Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.11.5 BGI Genomics Recent Development
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Details
11.12.2 Zhijiang Biology Business Overview
11.12.3 Zhijiang Biology Eukaryotic Transcriptome Sequencing Introduction
11.12.4 Zhijiang Biology Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.12.5 Zhijiang Biology Recent Development
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Company Details
11.13.2 Novogene Co., Ltd Business Overview
11.13.3 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Introduction
11.13.4 Novogene Co., Ltd Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.13.5 Novogene Co., Ltd Recent Development
11.14 Macrogen
11.14.1 Macrogen Company Details
11.14.2 Macrogen Business Overview
11.14.3 Macrogen Eukaryotic Transcriptome Sequencing Introduction
11.14.4 Macrogen Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.14.5 Macrogen Recent Development
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Company Details
11.15.2 Tsingke Biotechnology Co., Ltd. Business Overview
11.15.3 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Introduction
11.15.4 Tsingke Biotechnology Co., Ltd. Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025)
11.15.5 Tsingke Biotechnology Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
Bio Rad
Agilent Technologies
Qiagen NV
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang biology
Novogene
Macrogen
Tsingke Biotechnology Co., Ltd.
List of Tables
 Table 1. Global Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Total RNA
 Table 3. Key Players of Noncoding RNA
 Table 4. Global Eukaryotic Transcriptome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Eukaryotic Transcriptome Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Eukaryotic Transcriptome Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Eukaryotic Transcriptome Sequencing Market Share by Region (2020-2025)
 Table 8. Global Eukaryotic Transcriptome Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Eukaryotic Transcriptome Sequencing Market Share by Region (2026-2031)
 Table 10. Eukaryotic Transcriptome Sequencing Market Trends
 Table 11. Eukaryotic Transcriptome Sequencing Market Drivers
 Table 12. Eukaryotic Transcriptome Sequencing Market Challenges
 Table 13. Eukaryotic Transcriptome Sequencing Market Restraints
 Table 14. Global Eukaryotic Transcriptome Sequencing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Eukaryotic Transcriptome Sequencing Market Share by Players (2020-2025)
 Table 16. Global Top Eukaryotic Transcriptome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eukaryotic Transcriptome Sequencing as of 2024)
 Table 17. Ranking of Global Top Eukaryotic Transcriptome Sequencing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Eukaryotic Transcriptome Sequencing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Eukaryotic Transcriptome Sequencing, Headquarters and Area Served
 Table 20. Global Key Players of Eukaryotic Transcriptome Sequencing, Product and Application
 Table 21. Global Key Players of Eukaryotic Transcriptome Sequencing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Eukaryotic Transcriptome Sequencing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Type (2020-2025)
 Table 25. Global Eukaryotic Transcriptome Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Type (2026-2031)
 Table 27. Global Eukaryotic Transcriptome Sequencing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Application (2020-2025)
 Table 29. Global Eukaryotic Transcriptome Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Application (2026-2031)
 Table 31. North America Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Illumina Company Details
 Table 47. Illumina Business Overview
 Table 48. Illumina Eukaryotic Transcriptome Sequencing Product
 Table 49. Illumina Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 50. Illumina Recent Development
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Product
 Table 54. Thermo Fisher Scientific Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Bio-Rad Company Details
 Table 57. Bio-Rad Business Overview
 Table 58. Bio-Rad Eukaryotic Transcriptome Sequencing Product
 Table 59. Bio-Rad Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 60. Bio-Rad Recent Development
 Table 61. Agilent Technologies Company Details
 Table 62. Agilent Technologies Business Overview
 Table 63. Agilent Technologies Eukaryotic Transcriptome Sequencing Product
 Table 64. Agilent Technologies Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 65. Agilent Technologies Recent Development
 Table 66. QIAGEN Company Details
 Table 67. QIAGEN Business Overview
 Table 68. QIAGEN Eukaryotic Transcriptome Sequencing Product
 Table 69. QIAGEN Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 70. QIAGEN Recent Development
 Table 71. Roche Company Details
 Table 72. Roche Business Overview
 Table 73. Roche Eukaryotic Transcriptome Sequencing Product
 Table 74. Roche Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 75. Roche Recent Development
 Table 76. Pacific Biosciences Company Details
 Table 77. Pacific Biosciences Business Overview
 Table 78. Pacific Biosciences Eukaryotic Transcriptome Sequencing Product
 Table 79. Pacific Biosciences Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 80. Pacific Biosciences Recent Development
 Table 81. Eurofins Scientific Company Details
 Table 82. Eurofins Scientific Business Overview
 Table 83. Eurofins Scientific Eukaryotic Transcriptome Sequencing Product
 Table 84. Eurofins Scientific Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 85. Eurofins Scientific Recent Development
 Table 86. Azenta Company Details
 Table 87. Azenta Business Overview
 Table 88. Azenta Eukaryotic Transcriptome Sequencing Product
 Table 89. Azenta Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 90. Azenta Recent Development
 Table 91. LabCorp Company Details
 Table 92. LabCorp Business Overview
 Table 93. LabCorp Eukaryotic Transcriptome Sequencing Product
 Table 94. LabCorp Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 95. LabCorp Recent Development
 Table 96. BGI Genomics Company Details
 Table 97. BGI Genomics Business Overview
 Table 98. BGI Genomics Eukaryotic Transcriptome Sequencing Product
 Table 99. BGI Genomics Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 100. BGI Genomics Recent Development
 Table 101. Zhijiang Biology Company Details
 Table 102. Zhijiang Biology Business Overview
 Table 103. Zhijiang Biology Eukaryotic Transcriptome Sequencing Product
 Table 104. Zhijiang Biology Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 105. Zhijiang Biology Recent Development
 Table 106. Novogene Co., Ltd Company Details
 Table 107. Novogene Co., Ltd Business Overview
 Table 108. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Product
 Table 109. Novogene Co., Ltd Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 110. Novogene Co., Ltd Recent Development
 Table 111. Macrogen Company Details
 Table 112. Macrogen Business Overview
 Table 113. Macrogen Eukaryotic Transcriptome Sequencing Product
 Table 114. Macrogen Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 115. Macrogen Recent Development
 Table 116. Tsingke Biotechnology Co., Ltd. Company Details
 Table 117. Tsingke Biotechnology Co., Ltd. Business Overview
 Table 118. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Product
 Table 119. Tsingke Biotechnology Co., Ltd. Revenue in Eukaryotic Transcriptome Sequencing Business (2020-2025) & (US$ Million)
 Table 120. Tsingke Biotechnology Co., Ltd. Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Eukaryotic Transcriptome Sequencing Picture
 Figure 2. Global Eukaryotic Transcriptome Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Eukaryotic Transcriptome Sequencing Market Share by Type: 2024 VS 2031
 Figure 4. Total RNA Features
 Figure 5. Noncoding RNA Features
 Figure 6. Global Eukaryotic Transcriptome Sequencing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Eukaryotic Transcriptome Sequencing Market Share by Application: 2024 VS 2031
 Figure 8. Biomedical Field Case Studies
 Figure 9. Non-medical Field Case Studies
 Figure 10. Eukaryotic Transcriptome Sequencing Report Years Considered
 Figure 11. Global Eukaryotic Transcriptome Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Eukaryotic Transcriptome Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Eukaryotic Transcriptome Sequencing Market Share by Region: 2024 VS 2031
 Figure 14. Global Eukaryotic Transcriptome Sequencing Market Share by Players in 2024
 Figure 15. Global Top Eukaryotic Transcriptome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eukaryotic Transcriptome Sequencing as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Eukaryotic Transcriptome Sequencing Revenue in 2024
 Figure 17. North America Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Eukaryotic Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 19. United States Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Eukaryotic Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 23. Germany Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Eukaryotic Transcriptome Sequencing Market Share by Region (2020-2031)
 Figure 31. China Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Eukaryotic Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 39. Mexico Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 43. Turkey Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Eukaryotic Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Illumina Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 48. Bio-Rad Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 49. Agilent Technologies Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 50. QIAGEN Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 51. Roche Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 52. Pacific Biosciences Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 53. Eurofins Scientific Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 54. Azenta Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 55. LabCorp Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 56. BGI Genomics Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 57. Zhijiang Biology Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 58. Novogene Co., Ltd Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 59. Macrogen Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 60. Tsingke Biotechnology Co., Ltd. Revenue Growth Rate in Eukaryotic Transcriptome Sequencing Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Full length Transcriptome Sequencing Market Research Report 2024
Global RNA Analysis Transcriptomic Market Research Report 2024
Global RNA Seq Market Research Report 2024
Global Epigenome Sequencing Market Research Report 2024
Global Human Genome Sequencing Market Research Report 2024
Global Whole Transcriptomics Sequencing Market Insights Forecast to 2030
Global Human Gene Sequencing Market Research Report 2024
Global Bioinformatics Sequencing Service Market Research Report 2024
Global Genome Sequencing Service Market Research Report 2025
Global High Throughput Sequencing Technology Market Research Report 2025
Global DNA RNA Sequencing Kit Market Research Report 2024
mRNA Sequencing
Global Sequencing Services Market Research Report 2024
Global Human Microbiome Sequencing Market Research Report 2024
Global Small RNA Sequencing Market Research Report 2024
Global Next Gen Sequencing Data Analysis Market Research Report 2024
lncRNA Sequencing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Whole Genome Sequencing Service Market Research Report 2025
Global Third Generation Sequencing Market Research Report 2024
Global Targeted Sequencing Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions